Manufacturing Expertise Protein-Based Vaccine
Protein-based vaccines require reliable antigen expression, structural integrity, and scalable production to support clinical development and broader supply. Avid supports vaccine candidates through disciplined mammalian cell culture development and CGMP manufacturing aligned with regulatory expectations.
Overview
Accelerating Protein-Based Vaccine
Development with Proven Expertise
Key Development & Manufacturing Considerations
- Protein integrity
- Protein stability
- Product yield
- Purification efficiency
- Scalable production
How Avid Supports Vaccine Programs
- Process development and optimization
- Clinical CGMP manufacturing
- Analytical support
- Platform-based scale-up
Solutions
Explore Our Solutions
Learn More
Protein-Based Vaccine FAQs
Through defined process development, clinical manufacturing, and validated scale-up strategies.
Mammalian expression systems are commonly used to ensure proper protein folding, post-translational modifications and antigen quality.
Advance Your Vaccine
Program with Confidence
Connect with our team to discuss development timelines, manufacturing strategy, and scalable CGMP production.